Fraser R. Cummings
Southampton, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Exome sequencing directly implicates 68 genes in inflammatory bowel disease.
Journal: medRxiv : the preprint server for health sciences
Published: May 25, 2026
Comparative analysis of inflammatory bowel disease patient and service reported quality of care using 2019 and 2023 UK benchmarking data from more than 26,000 adult patient respondents and 154 IBD services.
Journal: Journal of Crohn's & colitis
Published: January 23, 2026
Factors associated with preference for in-person versus remote consultations in inflammatory bowel disease in the United Kingdom: secondary analysis of an online survey.
Journal: European journal of gastroenterology & hepatology
Published: October 28, 2025
Patient-reported real-world experience of risankizumab on-body device (OBD) for the treatment of Crohn's disease in the UK (COMMODUS).
Journal: Current medical research and opinion
Published: May 22, 2025
Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease: An individual participant data meta-analysis.
Journal: Journal of clinical gastroenterology
Published: February 05, 2025
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS).
Journal: International journal of clinical pharmacy
Published: December 15, 2023
Switching from intravenous to subcutaneous infliximab maintenance therapy in inflammatory bowel disease: Post hoc longitudinal analysis of a randomized trial.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: September 14, 2023
Stem-like T cells are associated with the pathogenesis of ulcerative colitis in humans.
Journal: Nature immunology
Published: June 15, 2023
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial.
Journal: Clinical drug investigation
Published: February 16, 2023
Establishing key performance indicators for inflammatory bowel disease in the UK.
Journal: Frontline gastroenterology
Published: February 13, 2023
Last Updated: 09/26/2026